| P2093 | author name string | Li Chen | |
| | Lili Zheng | |
| | Weiqiang Fei | |
| | Xiaotong Hu | |
| | Jiaxin Chen | |
| | Lumin Zhang | |
| | Lingfei Li | |
| | Shuiping Liu | |
| | Qinglan Shi | |
| P2860 | cites work | Global cancer statistics | Q22241238 |
| | CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo | Q24296427 |
| | Obesity and colorectal cancer: role of adipokines in tumor initiation and progression | Q26853740 |
| | Is retinol binding protein 4 a link between adiposity and cancer? | Q26862707 |
| | Clinical significance of tumor markers and an emerging perspective on colorectal cancer | Q37387757 |
| | miR-135b, a key regulator of malignancy, is linked to poor prognosis in human myxoid liposarcoma | Q37482708 |
| | A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma | Q37499747 |
| | Evaluation of Methylation Biomarkers for Detection of Circulating Tumor DNA and Application to Colorectal Cancer | Q37539515 |
| | Chronic Kidney Disease Alters Vitamin A Homeostasis via Effects on Hepatic RBP4 Protein Expression and Metabolic Enzymes. | Q37701154 |
| | Complications of colonoscopy: magnitude and management | Q37796354 |
| | Functional and structural features of adipokine family | Q38047622 |
| | Obesity related adipokines and colorectal cancer: a review and meta-analysis | Q38188042 |
| | Obesity, adipokines and cancer: an update. | Q38267868 |
| | Thrombospondin 2 regulates cell proliferation induced by Rac1 redox-dependent signaling. | Q39791304 |
| | Methylation of CLDN6, FBN2, RBP1, RBP4, TFPI2, and TMEFF2 in esophageal squamous cell carcinoma. | Q39872514 |
| | The tryptophan-rich motifs of the thrombospondin type 1 repeats bind VLAL motifs in the latent transforming growth factor-beta complex | Q40519781 |
| | Frequent HOXA11 and THBS2 promoter methylation, and a methylator phenotype in endometrial adenocarcinoma | Q40641250 |
| | Colorectal polyps and their relationship to cancer | Q41445971 |
| | Systemic inhibition of tumor growth and angiogenesis by thrombospondin-2 using cell-based antiangiogenic gene therapy. | Q42816971 |
| | Underexpression of mRNA in human hepatocellular carcinoma focusing on eight loci | Q43687623 |
| | The dimensions of the CRC problem | Q44801153 |
| | Serum retinal-binding protein 4 is positively related to insulin resistance in Chinese subjects with type 2 diabetes. | Q46132256 |
| | Serum retinol binding protein-4 and neutrophil gelatinase-associated lipocalin are interrelated in pancreatic cancer patients | Q46886669 |
| | Molecular interactions that confer latency to transforming growth factor-beta | Q47316441 |
| | Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. | Q51486811 |
| | Microvessel density and CpG island methylation of the THBS2 gene in malignant ovarian tumors. | Q54509271 |
| | Urinary 5-hydroxymethyluracil and 8-oxo-7,8-dihydroguanine as potential biomarkers in patients with colorectal cancer | Q60585013 |
| | The evolution of cancer of the colon and rectum | Q67352990 |
| | Inhibition of angiogenesis by thrombospondin-2 | Q70800437 |
| | Heparin-binding peptides from thrombospondins 1 and 2 contain focal adhesion-labilizing activity | Q72639618 |
| | Endothelial cell mitogenesis induced by LPA: inhibition by thrombospondin-1 and thrombospondin-2 | Q73031500 |
| | Thrombospondin-1 and -2 messenger RNA expression in epithelial ovarian tumor | Q77189223 |
| | Retinol binding protein-4 levels and clinical features of type 2 diabetes patients | Q80171630 |
| | Circulating Thrombospondin-2 and FGF-2 in Patients with Advanced Non-small Cell Lung Cancer: Correlation with Survival | Q85723941 |
| | Mechanisms linking excess adiposity and carcinogenesis promotion | Q27022929 |
| | Thrombospondin type 1 repeats interact with matrix metalloproteinase 2. Regulation of metalloproteinase activity | Q28141127 |
| | Thrombospondin 2 modulates collagen fibrillogenesis and angiogenesis | Q28142068 |
| | Evidence for colorectal cancer screening | Q28293022 |
| | Thrombospondin-1 is a major activator of TGF-beta1 in vivo | Q28513856 |
| | Estrogen receptor α in cancer-associated fibroblasts suppresses prostate cancer invasion via modulation of thrombospondin 2 and matrix metalloproteinase 3 | Q33705239 |
| | A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin | Q33763790 |
| | Association between obesity-related adipokines and colorectal cancer: a case-control study and meta-analysis | Q33801418 |
| | Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor | Q33947807 |
| | Modulation of growth and angiogenic potential of oral squamous carcinoma cells in vitro using salvianolic acid B. | Q33949948 |
| | Decreased concentrations of retinol-binding protein 4 in sera of epithelial ovarian cancer patients: a potential biomarker identified by proteomics | Q34054738 |
| | Pathology of the adenoma-carcinoma sequence: from aberrant crypt focus to invasive carcinoma | Q34073481 |
| | Proteomics analysis for finding serum markers of ovarian cancer | Q34182748 |
| | Obesity and cancer--mechanisms underlying tumour progression and recurrence | Q34425077 |
| | Potential of fecal microbiota for early-stage detection of colorectal cancer | Q34450065 |
| | Mechanisms linking obesity with cardiovascular disease | Q34590832 |
| | Cancer screening in the United States, 2007: a review of current guidelines, practices, and prospects | Q34613381 |
| | Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth. | Q34633187 |
| | Transcriptomics profiling study of breast cancer from Kingdom of Saudi Arabia revealed altered expression of Adiponectin and Fatty Acid Binding Protein4: Is lipid metabolism associated with breast cancer? | Q35042566 |
| | Serum levels of retinol-binding protein 4 and risk of colon adenoma. | Q35127648 |
| | How industry is approaching the search for new diagnostic markers and biomarkers | Q35641788 |
| | Alcohol Drinking Obliterates the Inverse Association Between Serum Retinol and Risk of Head and Neck Cancer | Q35858231 |
| | Retinoid and carotenoid status in serum and liver among patients at high-risk for liver cancer | Q35939958 |
| | High-risk oral leukoplakia is associated with aberrant promoter methylation of multiple genes | Q36038578 |
| | CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells | Q36276395 |
| | Regulation of tumor angiogenesis by thrombospondin-1. | Q36365861 |
| | Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch | Q36576720 |
| | Thrombospondin 2 expression is correlated with inhibition of angiogenesis and metastasis of colon cancer | Q36617350 |
| | Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy | Q36689936 |
| | Nitric oxide and its gatekeeper thrombospondin-1 in tumor angiogenesis. | Q36731944 |
| | Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis | Q36775071 |
| | Thrombospondin-based antiangiogenic therapy | Q36845405 |
| | Thrombospondins in cancer | Q37056249 |
| | THBS2 is a Potential Prognostic Biomarker in Colorectal Cancer | Q37261166 |
| P433 | issue | 54 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal cancer | Q188874 |
| | biomarker | Q864574 |
| P304 | page(s) | 92254-92264 | |
| P577 | publication date | 2017-09-21 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | RBP4 and THBS2 are serum biomarkers for diagnosis of colorectal cancer | |
| P478 | volume | 8 | |